Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aequus Pharmaceuticals Inc V.AQS

Alternate Symbol(s):  AQSZF

Healthcare
Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing, advancing, and promoting differentiated products. The Company is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:AQS)

Aequus Reports Third Quarter 2023 Financial Highlights and General Update

TheNewsWire November 29, 2023

Aequus Announces New Financing

TheNewsWire October 20, 2023

Aequus Announces New Financing and Provides Launch Update of Zimed Preservative Free (Bimatoprost 0.03%)

TheNewsWire October 6, 2023

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

GlobeNewswire August 29, 2023

Aequus Announces Zimed PF Now Available in Canada

GlobeNewswire August 24, 2023

Aequus Announces Zimed PF Website Launch

GlobeNewswire August 22, 2023

Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada

GlobeNewswire August 18, 2023

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)

GlobeNewswire July 6, 2023

Aequus Provides General Update and First Quarter 2023 Financial Highlights

GlobeNewswire May 30, 2023
View More News ››

Opinion & Analysis (TSXV:AQS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:AQS)

Gov. publication

National-Vision-Health-Desk-Outline_FR.pdf (cos-sco.ca)
yc2022 - January 14, 2024

RE:RE:Volume

JohnTool321 - October 16, 2022

RE:RE:New Seeking Alpha report

Lisagerrard17 - May 30, 2022

RE:Volume

Larrymartin77 - May 28, 2022

RE:RE:New Seeking Alpha report

Only that report is just about a year old now.
WsrThanWenYungr - February 17, 2022

RE:New Seeking Alpha report

I saw the report also
BlacknBulls - February 5, 2022
View more Bullboard ››

AKITA Drilling Ltd

AKITA Drilling Ltd

AKITA Drilling Ltd. is a Canada-based intermediate land drilling contractor. The Company and its subsidiaries provide ...
View More »